Fingerprint
Dive into the research topics of 'Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically